Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective agonists and antagonists to thyroid hormone action.

Zaki Kraiem1

  • 1Technicon Faculty of Medicine, Carmel Medical Center, 7 Michal Street, Haifa 34362, Israel. zkraiem@clalit.org.il

Thyroid : Official Journal of the American Thyroid Association
|May 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Growth inhibition of human thyroid carcinoma and goiter cells in vitro by the isoflavone derivative 7-(O)-carboxymethyl daidzein conjugated to N-t-boc-hexylenediamine.

Thyroid : official journal of the American Thyroid Association·2012
Same author

Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.

Molecular cancer therapeutics·2010
Same author

Thyroid hormone biosynthesis - the importance of the sodium/iodide symporter (NIS).

Pediatric endocrinology reviews : PER·2006
Same author

Recent advances in thyroid research: selective thyroid hormone receptor modulators (STRMs).

Pediatric endocrinology reviews : PER·2006
Same author

Human thyrotropin (TSH) variants designed by site-directed mutagenesis block TSH activity in vitro and in vivo.

Endocrinology·2005
Same author

Early embryo-endometrial signaling modulates the regulation of matrix metalloproteinase-3.

Fertility and sterility·2004

Selective thyromimetics offer thyroid hormone benefits like cholesterol reduction without side effects. New antagonists aim to treat hyperthyroidism, but clinical trials are needed to confirm their therapeutic value.

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Thyroid hormones regulate metabolism, impacting cholesterol, weight, muscle, bone, and heart rate.
  • Adverse effects of thyroid hormones necessitate targeted therapeutic strategies.
  • Hyperthyroidism involves excessive thyroid hormone action, requiring effective treatments.

Purpose of the Study:

  • To review the development of selective thyromimetics and hyperthyroid treatments.
  • To assess the potential of novel agents in managing thyroid hormone-related conditions.
  • To highlight the need for clinical validation of these therapeutic approaches.

Main Methods:

  • Design and evaluation of selective thyromimetics.
  • Synthesis of antagonists targeting thyroid hormone or thyrotropin receptors.

Related Experiment Videos

  • Review of preclinical data on therapeutic efficacy and safety.

    • Main Results:

    • Selective thyromimetics mimic beneficial thyroid hormone effects (e.g., lipid-lowering, weight reduction).
    • These agents avoid adverse effects on muscle, bone, and heart rate.
    • Antagonists show promise in blocking thyroid hormone action at receptor levels.

    Conclusions:

    • Selective thyromimetics and receptor antagonists represent promising therapeutic avenues.
    • Further clinical trials are essential to establish the efficacy and safety of these agents.
    • These developments could lead to improved management of thyroid-related disorders.